Presentation is loading. Please wait.

Presentation is loading. Please wait.

TL1A Expression in Human IBD and Animal Models

Published byIsrael Ormerod Modified over 9 years ago

Similar presentations

Presentation on theme: "TL1A Expression in Human IBD and Animal Models"— Presentation transcript:

1 TL1A Expression in Human IBD and Animal Models
Bala Manickam Pfizer ACVP-STP fellow, Anatomic pathology resident University of Georgia, Athens GA

2 TL1A & DR3 - Biology TL1A (aka TNFSF15) is a recently identified member of TNF superfamily. Expressed by monocytes, macrophages, dendritic cells, synovial fibroblasts, chondrocytes and endothelial cells Increased expression when stimulated by cytokines, immune complexes and micro-organisms. Its Cell surface receptor DR3 is (aka TNFSF25, WSL-1, TRAMP ands LARD) is mainly expressed by T cells TL1A-DR3 interaction amplifies the DR3 expression and mediates the inflammatory effects. DR3 is a type I cytokine receptor with an intracytoplasmic death domain DcR3 is the decoy receptor that does not have an intracytplasmic domain and hence inhibits the downstream signaling Nat Rev Rheumatol Feb;6(2):67-8 Biochem Pharmacol Apr 1;81(7):838-47

3 Inflammatory Bowel Disease
Human IBD IBD represents an important chronic disease affecting the GI tract of man and domesticated animal species. The 2 IBD entities in humans are Crohn’s disease (CD) and Ulcerative colitis (UC). Immune mediated - responds to immunomodulatory drugs The pathogenesis of IBD involves: Failure of immune regulation. Genetic susceptibility. Environmental triggers (microbial flora). Disruption of the mucosal barrier. Mouse models of IBD DSS (Dextran sulphate) colitis: Oral administration of this sulphated polysaccharide to mice induces a self limiting colitis TNBS (Trinitrobenzene sufonic acid) colitis: Colonic inflammation is induced by intrarectal administration of TNBS dissolved in 50% ethanol Canine IBD Small intestine: Lymphocytic-plasmacytic enteritis (LPE), eosinophilic enteritis and eosinophilic gastro-enteritis (EGE) Large intestine; Lymphocytic-plasmacytic colitis, eosinophilic colitis, histiocytic ulcerative colitis (HUC) (mainly PAS-positive macrophages), and regional granulomatous colitis (mainly PAS-negative macrophages)

4 TL1A & DR3 expression in human IBD
Healthy Person CD UC TL1A TL1A: CD- lymphocytes and macrophages; UC- Plasma cells DR3: Increased numbers of immunoreactive cells were detected in the lamina propria lymphocytes from involved areas of IBD patients DR3 J Immunol 2003;171;

5 TL1A & DR3 : Evidence of Efficacy
Gut bacteria Control anti TL1A TNBS colitis DSS colitis Fig 1: Attenuation of TNBS colitis by anti-TL1A mAb. Fig 2: DSS model colitis; both prophylactic and therapeutic Fig 3: TL1A transgenic mice spontaneously develop colitis; DR3 KO attenuates colitis Proposed mechanism Control DR3 KO GASTROENTEROLOGY 2008;135:552–567 Mucosal Immunology (2011) 4, ;

6 Rationale for current study
Up-regulation of TL1A and DR3 in human CD and UC and in rodent IBD models TL1A and DR3 deficiency attenuates murine IBD IBD occurs spontaneously in dogs. Because of this, and because it shares a similar immunopathology, it may provide valuable mechanistic insight into the disease in humans. Studying IBD in spontaneous and induced models may provide insights into how we model the disease in laboratory mice

7 Hypothesis By characterizing and comparing expression profile of TL1A and other critical immunological markers in murine IBD to people, we may further validate (and perhaps even uncover) therapeutic targets for human IBD.

8 Objectives Compare and characterize the staining of TL1A & DR3 in intestinal tissues obtained from DSS and TNBS mouse colitis models, human IBD, canine IBD and normal colons from cynomolgus monkeys. Compare the staining characteristics of mast cells in intestinal tissues obtained from DSS and TNBS mouse colitis models, human IBD and canine IBD. Compare the expression of T&B cells in different models of IBD.

9 Experimental design Groups Number of subjects Number of slides/subject
Total number of slides DSS (Mouse) 5 10 50 TNBS (Mouse) Normal colon (Mouse) UC (Human) 6 36 CD (Human) Normal colon (Human) Normal colon (Primate) 25 IBD (Dog) Normal colon (Dog)

10 Reagents Anti-human TL1A mAb (made by Pfizer, optimized for IHC)
Homology to mouse, rat: 92% Homology to dog (predicted): 86% Anti-human DR3 mAb (made by Novus Biol) The immunogenic peptide shares 44% homology with canine DR3 (XP_ ) 88% homology with primate DR3 (XM_ CD3, CD45RB220, CD20, Toluidine blue Pfizer Internal Use

11 Results: TL1A expression
Normal CD UC Human Naïve DSS TNBS Scattered cells within the lamina propria of the normal/naïve are positive for TL1A TL1A expression is increased in IBD conditions in both human cases as well as in murine models. A moderate to variably strong staining of the cytoplasm and the membrane of the Non T, non B, Non neutrophilic cell type was consistently present within the inflamed areas in mice and humans Mice

12 Results: TL1A expression
Cynomolgus Human Mice Vasculature (+) Germinal center (-) TL1A expression in the vasculature (endothelial cells) were consistent in cynomolgus, humans and mice tissues and served as an internal control GALT did not stain positive for TL1A in both mice and human IBD tissues DR3: The lymphocytes infiltrating the lamina propria and the submucosa in crohn’s disease were strongly positive for DR3. The staining was localized to the nucleus, cytoplasm and the cell membrane CD Lamina propria DR3

13 Mast cells in IBD – Dog, Mice
Naive IBD H&E T-blue Dog: Only rare mast cells are present within the control and the IBD dogs Mice: Only rare mast cells are present in Naïve, DSS and TNBS colitis; There is no difference in the expression of Mast cells between the groups Naive DSS TNBS

14 B-lymphocytes-Human IBD
Normal CD UC Germinal center Lamina propria GALT hyperplasia is present in patients with CD and UC Increased numbers of B-lymphocytes are present within the lamina propria of the CD and UC patients when compared to normal individual

15 B-lymphocytes-Mice IBD
Naive DSS TNBS Germinal center Lamina propria GALT hyperplasia is present in DSS and TNBS colitis Increased numbers of B-lymphocytes are present within the lamina propria of the CD and UC patients when compared to normal individual Basal level expression of B cells within the normal colon was similar in mice and humans B & T cells within the GALT and the lamina propria were markedly increased in IBD patients when compared to healthy controls that was consistent with mice models

16 T-lymphocytes-Human IBD
Normal CD UC Germinal center Lamina propria GALT hyperplasia is present in patients with CD and UC Increased numbers of T-lymphocytes are present within the lamina propria of the CD and UC patients when compared to normal individual

17 T-lymphocytes-Mice IBD
Naive DSS TNBS Germinal center Lamina propria Increased numbers of B-lymphocytes are present within the lamina propria of the CD and UC patients when compared to normal individual Basal level expression of T cells within the normal human colon was increased when compared to the mice models

18 B & T lymphocytes- Cynomolgus
B-cells T-cells Germinal center There are few scattered B-lymphocytes within the lamina propria of naïve Cynomolgus colon Germinal center stains positive for B-lymphocytes There are few scattered T-lymphocytes within the lamina propria of naïve Cynomolgus colon Lamina propria

19 Conclusion TL1A: B&T-lymphocytes: Mast cells:
The expression of TL1A was similar and consistent across the species TL1A was up regulated in IBD when compared to the Naive/healthy patients This data not only validates the existing murine IBD models but also indicates that TL1A could be a druggable target in IBD We also uncovered that Cynomolgus shares similar staining characteristics with human and murine IBD tissues and thus can probably be a good model to study human IBD B&T-lymphocytes: Increased numbers of both B & T cells in the lamina propria in cases of IBD, suggests a potential role for immune activation in IBD Mast cells: In our study, We could not detect any difference in the expression of mast cells in both naïve and or IBD patients in both murine and Dog cases.

20 Acknowledgement Dr. Timothy LaBranche (Industry Mentor)
Dr. Elizabeth Howerth (Academic Mentor) Dr. Zaher Radi (Pfizer) Dr. Shawn O’ Neil (Pfizer) Jameel Syed (Pfizer) Zachery Stewart (Pfizer) University of Georgia ACVP-STP Coalition Studies were funded and supported by DRSD, Pfizer

21 Thank you! Pfizer Internal Use

Download ppt "TL1A Expression in Human IBD and Animal Models"

Similar presentations

Cleveland Clinic Foundation, Cleveland, USA

Cleveland Clinic Foundation, Cleveland, USA
Opportunistic Bacterial Infections in Inflammatory Bowel Disease By: Christina Philips.

Opportunistic Bacterial Infections in Inflammatory Bowel Disease By: Christina Philips.
The Microbiome: What’s the immune system got to do with it?

The Microbiome: What’s the immune system got to do with it?
Ursodeoxycholic acid inhibits colonic mucosal cytokine release and prevents colitis in a mouse model of disease Joseph BJ Ward 1, Orlaith Kelly 1,2, Siobhan.

Ursodeoxycholic acid inhibits colonic mucosal cytokine release and prevents colitis in a mouse model of disease Joseph BJ Ward 1, Orlaith Kelly 1,2, Siobhan.
A8-023287 Tamas Nagy, DVM, PhD Department of Pathology College of Veterinary Medicine University of Georgia Presented at SEVPAC 2008 – Permission granted.

A Tamas Nagy, DVM, PhD Department of Pathology College of Veterinary Medicine University of Georgia Presented at SEVPAC 2008 – Permission granted.
JAIMEE DOUCETTE T HELPER CELLS IN IBD. OVERVIEW Background Information on T Helper cells What is known about Th cells in IBD? What is still unknown about.

JAIMEE DOUCETTE T HELPER CELLS IN IBD. OVERVIEW Background Information on T Helper cells What is known about Th cells in IBD? What is still unknown about.
Lauri Diehl, Sr. Scientist/Pathologist, Genentech December 5, 2014.

Lauri Diehl, Sr. Scientist/Pathologist, Genentech December 5, 2014.
An Essential Role for Interleukin 10 in the Function of Regulatory T Cells That Inhibit Intestinal Inflammation Barrette Kathleen – Dreesen Erwin Asseman.

An Essential Role for Interleukin 10 in the Function of Regulatory T Cells That Inhibit Intestinal Inflammation Barrette Kathleen – Dreesen Erwin Asseman.
Hannover Medical School February 15 th 2010 The gut microbiota shapes intestinal immune response during health and disease Round and Mazmanian, Nature.

Hannover Medical School February 15 th 2010 The gut microbiota shapes intestinal immune response during health and disease Round and Mazmanian, Nature.
Crohn’s disease - A Review of Symptoms and Treatment

Crohn’s disease - A Review of Symptoms and Treatment
Ulcerative Colitis. Which of the following would not be associated with UC Toxic megacolon Granulomas Pseudopolyps Primary sclerosing cholangitis.

Ulcerative Colitis. Which of the following would not be associated with UC Toxic megacolon Granulomas Pseudopolyps Primary sclerosing cholangitis.
“Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis” Lee YK, Menezes JS, Umesaki Y, & Mazmanian SK PNAS.

“Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis” Lee YK, Menezes JS, Umesaki Y, & Mazmanian SK PNAS.
Immunotolerance Christoph Mueller

Immunotolerance Christoph Mueller
North American Neuromodulation Society Meeting 2012 Harnessing the Inflammatory Reflex: Using Neuromodulation as a Novel Approach to Treat Chronic Inflammatory.

North American Neuromodulation Society Meeting 2012 Harnessing the Inflammatory Reflex: Using Neuromodulation as a Novel Approach to Treat Chronic Inflammatory.
KRISTEN DOSTIE Alteration of Chemotaxis in the Gut of IBD Patients.

KRISTEN DOSTIE Alteration of Chemotaxis in the Gut of IBD Patients.
1 Modulation of inflammatory processes in DSS-induced colitis model versus gastrointestinal acute radiation syndrome with AVX-470m, an oral polyclonal.

1 Modulation of inflammatory processes in DSS-induced colitis model versus gastrointestinal acute radiation syndrome with AVX-470m, an oral polyclonal.
Crohn’s Disease & Mycobacterial Infections Kimberly Persley, MD October 19, 2005.

Crohn’s Disease & Mycobacterial Infections Kimberly Persley, MD October 19, 2005.
Contact Information: Tel: 304 696-3892.

Contact Information: Tel:
P1586 THE FIRST JAK1-SELECTIVE INHIBITOR, FILGOTINIB, DISPLAYS SIMILAR MOLECULAR ACTIVITY IN THE GUT OF MICE WITH DSS-INDUCED COLITIS AND IN CULTURES OF.

P1586 THE FIRST JAK1-SELECTIVE INHIBITOR, FILGOTINIB, DISPLAYS SIMILAR MOLECULAR ACTIVITY IN THE GUT OF MICE WITH DSS-INDUCED COLITIS AND IN CULTURES OF.
Bioengineering Bacterial Derived Immunomodulants: a Novel IBD Therapeutic Approach Andrew S. Neish, MD Department of Pathology Emory University School.

Bioengineering Bacterial Derived Immunomodulants: a Novel IBD Therapeutic Approach Andrew S. Neish, MD Department of Pathology Emory University School.

Similar presentations

Ads by Google